MétaCan
Menu
Back to cohort
Record W4413375901 · doi:10.1001/jamaoncol.2025.2590

Predicting Chronic Kidney Disease After Cisplatin Treatment Using Population-Level Data

2025· article· en· W4413375901 on OpenAlexaffabout
Robert C. Grant, Jiang Chen He, Ning Liu, Sho Podolsky, Faiyaz Notta, Marzyeh Ghassemi, Steven Gallinger, Andrea Knežević, Sheron Latcha, Edgar A. Jaimes, Abhijat Kitchlu, Kelvin Chan

Bibliographic record

VenueJAMA Oncology · 2025
Typearticle
Languageen
FieldMedicine
TopicChemotherapy-induced organ toxicity mitigation
Canadian institutionsHealth Sciences CentreSunnybrook Health Science CentreInstitute for Clinical Evaluative SciencesPrincess Margaret Cancer CentreUniversity Health NetworkOntario Institute for Cancer Research
FundersNational Cancer Institute
KeywordsMedicineKidney diseaseInternal medicineCohortPopulationRetrospective cohort studyRenal functionIncidence (geometry)Environmental health

Abstract

fetched live from OpenAlex

Importance: Cisplatin is a widely used treatment for cancer that can permanently damage the kidneys. Treatment modifications and other strategies may prevent chronic kidney disease (CKD) in patients at risk; however, the incidence and predictability of CKD following cisplatin treatment remain poorly understood. Objective: To characterize the incidence of CKD after cisplatin treatment and evaluate prediction models. Design, Setting, and Participants: In this population-based prognostic study, prediction models were developed based on a retrospective cohort study of patients who received cisplatin chemotherapy for nonhematologic cancer in an outpatient setting between July 1, 2014, and June 30, 2017. Models were tested on a temporal-test cohort of patients from Ontario, Canada, who started treatment between July 1, 2017, and June 30, 2020, and an external-test cohort of patients from a single center in the United States. Data were analyzed from May 1, 2021 to May 7, 2025. Exposures: Predictive features included demographics, cancer diagnosis, cisplatin dose and schedule, comorbidities, laboratory testing, and patient-reported symptoms. Main Outcomes and Measures: The outcomes were CKD (estimated glomerular filtration rate [eGFR] <60 mL/min/1.73 m2) and the eGFR after cisplatin treatment. Measures included the area under the receiver operating characteristic curve and the mean absolute error (MAE). Results: The population-level cohort included 9521 patients (median age, 63 years [IQR, 56-70 years]; 4841 men [50.8%]). Among the 9010 patients without pretreatment CKD, 1228 (13.6%) developed CKD, 81 (0.9%) developed grade 4 or worse CKD, and 16 (0.18%) required dialysis. The eGFR decreased by a mean of 8.1 mL/min/1.73 m2 (95% CI, 7.8-8.4 mL/min/1.73 m2). A simple spline-based regression model based solely on the pretreatment eGFR predicted posttreatment CKD in the temporal-test cohort (area under the curve, 0.80 [95% CI, 0.78-0.82]) and the external-test cohort (area under the curve, 0.73 [95% CI, 0.66-0.78]). Similarly, the posttreatment eGFR was predicted by a spline regression based solely on the pretreatment eGFR (temporal-test MAE, 12.6 mL/min/1.73 m2 [95% CI, 12.3-13.0 mL/min/1.73 m2]; external-test MAE, 14.3 mL/min/1.73 m2 [95% CI, 13.2-15.5 mL/min/1.73 m2]). Complex machine learning systems incorporating all features failed to improve predictions over the univariable models. Conclusions and Relevance: This study found that cisplatin treatment was followed by a predictable decrease in the eGFR, placing patients with a lower baseline eGFR at the highest risk of CKD. A simple model based on the pretreatment eGFR predicts CKD risk and could guide clinical decision-making.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.001
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.175
Threshold uncertainty score0.660

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.067
GPT teacher head0.375
Teacher spread0.308 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations2
Published2025
Admission routes2
Has abstractyes

Explore more

Same venueJAMA OncologySame topicChemotherapy-induced organ toxicity mitigationFrench-language works237,207